Ctic stock earnings
WebMar 17, 2024 · CTI BioPharma ( NASDAQ:CTIC – Get Rating) last issued its quarterly earnings data on Monday, March 6th. The biopharmaceutical company reported ($0.14) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.04). CTI BioPharma had a negative net margin of 172.37% and a negative return on … WebAug 1, 2024 · Get the latest CTI BioPharma Corp. (CTIC) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals. ... Financials Dividends Adv. Charts Earnings Options ...
Ctic stock earnings
Did you know?
Web2 days ago · SEATTLE, Wash., April 12, 2024 /PRNewswire/ -- CTI BioPharma Corp. (Nasdaq: CTIC), a commercial biopharmaceutical company focused on the development and commercialization of novel targeted therapies for blood-related cancers, today announced that the management team will participate in two upcoming investor … WebStock is heavily short : 20% of float is short 80% Institutional investors. nice swing opportunity for a re-bounce to the upper "resistance" channel line. NASDAQ:CTIC Stock had decent drop right after earnings to the lowest channel support line. Stock is heavily short : 20% of float is short 80% Institutional investors.
WebApr 3, 2024 · CTIC Complete CTI BioPharma Corp. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. WebApr 12, 2024 · While ratings are subjective and will change, the latest CTI BioPharma ( CTIC) rating was a reiterated with a price target of $0.00 to $9.00. The current price CTI BioPharma ( CTIC) is trading at ...
WebCTI BioPharma (CTIC) Reports Q4 Loss, Lags Revenue Estimates. CTI BioPharma (CTIC) delivered earnings and revenue surprises of -55.56% and 15.24%, respectively, for the quarter ended December 2024 ... WebMar 17, 2024 · CTI BioPharma Corp. analyst estimates, including CTIC earnings per share estimates and analyst recommendations.
Web1 day ago · CTI BioPharma Corp. (Nasdaq: CTIC), a commercial biopharmaceutical company focused on the development and commercialization of novel targeted therapies …
WebApr 10, 2024 · CTI BioPharma (CTIC) delivered earnings and revenue surprises of -55.56% and 15.24%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock? 1 month ago - Zacks Investment Research organigrowhairco product reviewWeb20 hours ago · In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower ... how to use jade roller faceWebApr 13, 2024 · As a result, investors might want to see an improvement in the stock’s price before the company announces its earnings report. Analysts are projecting the company’s earnings per share (EPS) to be -$0.1, which is expected to increase to -$0.08 for fiscal year -$0.43 and then to about -$0.29 by fiscal year 2024. organika activated oxygenWebMar 28, 2024 · CTI BioPharma Corp. (CTIC) latest earnings report: revenue, EPS, surprise, history, news and analysis. how to use jagannatha horaWebApr 12, 2024 · While ratings are subjective and will change, the latest CTI BioPharma ( CTIC) rating was a reiterated with a price target of $0.00 to $9.00. The current price CTI … how to use jade roller under eyesWebMar 14, 2024 · Shares of CTIC stock opened at $4.47 on Tuesday. The stock has a market capitalization of $589.32 million, a price-to-earnings ratio of -5.26 and a beta of 0.91. CTI BioPharma has a twelve month ... how to use jade eye rollerWebStock Price Forecast. The 9 analysts offering 12-month price forecasts for CTI Biopharma Corp have a median target of 10.00, with a high estimate of 15.00 and a low estimate of … how to use jadx